NICE umiyu paru pi tyen acel pi yath manyen ma copo konyo awiya, juma nyathin man ju ma fodi gitie aradu ma gibe nwangu yath pa two kanca ni gwoko ith migi marac.
Cisplatin ubedo yath ma tek ma jutiyo kudu pi thiethu kit two mapol pa awiya. Ikind kare, cisplatin copo dongo i it ma iye man nyayu lyethu man ret ma julwongo ni ototoxicity, ma en e the lembe acel ma nyayu rwenyo ith.
Lembe ma jugoro mir ajiki uketho tic ku anhydrous sodium thiosulfate, ma julwongo bende ni Pedmarqsi man ma juyike ku Norgine, pi juku winyo ma rac ma wok kud i cisplatin chemotherapy i awiya ma oro migi dwi acel nitundo apar wi abiro ku two ma tek ma unyai ungo i kum dhanu mukende.
Ikind 60% pa awiya ma jutiyo kudu ku cisplatin gibinwangu two mi winjo ma rii, ku 283 two manyen mi winyo ma rac ma junwango i awiya ma fodi gitie ku oro 18 ungo i England ikind oro 2022 ku 2023.
Yath ne, ma jumiyo ni nurse nyo daktari, timo tic pare ni mako cisplatin ma cells utingo ngo man juku tic pare, man eketho cells mi ith kud unyothre. Tic ku sodium thiosulfate anhydrous nyayu ngo adwogi marac ikum cisplatin chemotherapy.
Juyiko nia i oro mir acel mi ketho cik pi tic ku anhydrous sodium thiosulfate, awiya ma romo 60 million man ju ma fodi gitie aradu i England gibibedo ku twero mi nwangu yath ne.
Turo winji pi yath pa two kanca copo bedu ku adwogi marac ikum awiya man jupagi, pieno wabedo kud anyonga ni bedo ku copo mi nyuthu yore manyen mi yath eni.
Eni ubedo yath mir acel ma juporo ni juku man jwigo peko mi winjo man ebi bedu ku adwogi madit ikum kwo pa awiya man ju ma fodi gitie aradu.
Helen umediri: "Lembe ma wabemiyu pi yath manyen eni nyutho miti pa NICE mi ketho wigi ikum gin ma pire tek: miyo kony maber ni jurutwo pio pio man ni neno ni ju ma culu ajok gibedo ku piny maber."
Lembe ma wok kud i lembe ario ma jutimo unyutho nia yath ne udwoko piny wel mi winyo ma rac pa awiya ma ugamu cisplatin chemotherapy. Temo acel mi yath unwangu niya awiya ma ginwangu cisplatin chemotherapy man anhydrous sodium thiosulfate gibedo ku 32.7% mi rwenyo winji, ka juporo ku 63% mi rwinyu pa awiya ma ginwangu cisplatin chemotherapy kende.
I lembe mange, 56.4% pa awiya ma ginwangu cisplatin kende gi nwango peko mi winji, ka juporo ku 28.6% pa awiya ma ginwangu cisplatin man anhydrous sodium thiosulfate.
Tembe ne de unyutho nia ka awiya gibedo ku peko mi winjo, ebedo marac ungo ikind ju ma gitiyo ku anhydrous sodium thiosulfate.
Jurunyodo giwacu ni judongo pa NICE nia ka winjo marac utime pi cisplatin chemotherapy, ecopu nyayu peko ikum wec man dongo pa dhok, man tic i somu man i pacu.
Wabedo kud anyonga ni tito ni yath ma nyen eni jubi tiyo kudu i kum ju ma fodi gitie aradu ma gibe nwangu yath pa two kanca pi jwigo winjo marac calu adwogi pa cisplatin chemotherapy.
Ralph umediri: "Wabekuru neno yath eni i ot yath i ngom zoo man wageno nia awiya ceke ma copo nwangu bero kud i iye bino nwangu yath ma laro kwo. Wafoyo jukony mwa pi kony migi, ma uketho RNID umio ni NICE paru man giranyutha ma pire tek pi konyo ni ketho yath eni ubed nuti i UK. Eni ubedo wang mir acel ma juyubu yath eni pi juku rweny pa two. man juyero ni jutii kudu i NHS. Eni ubedo lembe ma pire tek ma bi miyo ju ma gi ketho lim man gi yubu yore mi cango two ma winjo ngo gen ni gicopo kelo yath i cuk.
Thek eca bibedo nuti i NHS i England ikind dwi adek ingey wodhu pa cik pa NICE.
Dul ne umondo i winjiri mi kuloka ma pire tek mi mio anhydrous sodium thiosulfate ni National Health Service i wel ma piny.